FDA Approved: ABIRATERONE ACETATE — Supplemental Application (Dr. Reddys Laboratories Inc)

View source ↗

Summary

FDA approved Dr. Reddy's Laboratories' supplemental application for abiraterone acetate, enabling a generic version of the cancer drug.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Castration-resistant Prostate Cancer
• Prostate Cancer

Drugs mentioned

• Abiraterone acetate (Abiraterone acetate)

Snippet

SUPPL AP for ABIRATERONE ACETATE (ABIRATERONE ACETATE)